Dr. Bunn on the Response of Immunotherapy in Lung Cancer

Paul A. Bunn Jr, MD
Published: Wednesday, Sep 06, 2017



Paul A. Bunn Jr, MD, distinguished professor, Division of Medical Oncology/University of Colorado, James Dudley Chair in Lung Cancer Research, University of Colorado Denver, 2014 Giant of Cancer Care in Lung Cancer, discusses the response of immunotherapy in patients with lung cancer.

Patients with stable disease may have a true pathologic response to immunotherapy. If the patient seems to benefitting, they can stop receiving treatment and repeat the CT scan, explains Bunn.
 
SELECTED
LANGUAGE


Paul A. Bunn Jr, MD, distinguished professor, Division of Medical Oncology/University of Colorado, James Dudley Chair in Lung Cancer Research, University of Colorado Denver, 2014 Giant of Cancer Care in Lung Cancer, discusses the response of immunotherapy in patients with lung cancer.

Patients with stable disease may have a true pathologic response to immunotherapy. If the patient seems to benefitting, they can stop receiving treatment and repeat the CT scan, explains Bunn.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x